• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Raptor Pharmaceutical Corp

+ Add to Watchlist

XYXR:GR

6.005 EUR 0.266 4.63%

As of 02:16:12 ET on 04/17/2014.

Snapshot for Raptor Pharmaceutical Corp (XYXR)

Open: 6.011 Day's Range: 6.005 - 6.011 Volume: 0
Previous Close: 5.739 52wk Range: 4.300 - 13.865 1-Yr Rtn: +37.95%

Stock Chart for XYXR

No chart data available.
  • XYXR:GR 6.005
  • 1D
  • 1M
  • 1Y
5.739
Interactive XYXR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XYXR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.5740
Est. PEG Ratio -
Market Cap (M EUR) 375.19
Shares Outstanding (M) 62.48
30 Day Average Volume 464
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XYXR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for XYXR

Raptor Pharmaceuticals Corporation provides medical research services. The Company develops, manufactures, and commercializes medicines and clinical treatment for neurodegenerative disorder and liver disease. Raptor Pharmaceuticals serves the medical field worldwide.

Llew KeltnerChairmanChristopher M StarrCEO/Co-Founder
Georgia ErbezCFO/Treasurer/SecretaryThomas E Daley "Ted"Chief Business Officer
More Company Profile & Key Executives for XYXR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil